Citation
Kobayashi, Haruo, et al. "Brain Regional Acetylcholinesterase Activity and Muscarinic Acetylcholine Receptors in Rats After Repeated Administration of Cholinesterase Inhibitors and Its Withdrawal." Toxicology and Applied Pharmacology, vol. 219, no. 2-3, 2007, pp. 151-61.
Kobayashi H, Suzuki T, Sakamoto M, et al. Brain regional acetylcholinesterase activity and muscarinic acetylcholine receptors in rats after repeated administration of cholinesterase inhibitors and its withdrawal. Toxicol Appl Pharmacol. 2007;219(2-3):151-61.
Kobayashi, H., Suzuki, T., Sakamoto, M., Hashimoto, W., Kashiwada, K., Sato, I., Akahori, F., & Satoh, T. (2007). Brain regional acetylcholinesterase activity and muscarinic acetylcholine receptors in rats after repeated administration of cholinesterase inhibitors and its withdrawal. Toxicology and Applied Pharmacology, 219(2-3), 151-61.
Kobayashi H, et al. Brain Regional Acetylcholinesterase Activity and Muscarinic Acetylcholine Receptors in Rats After Repeated Administration of Cholinesterase Inhibitors and Its Withdrawal. Toxicol Appl Pharmacol. 2007;219(2-3):151-61. PubMed PMID: 17188317.
TY - JOUR
T1 - Brain regional acetylcholinesterase activity and muscarinic acetylcholine receptors in rats after repeated administration of cholinesterase inhibitors and its withdrawal.
AU - Kobayashi,Haruo,
AU - Suzuki,Tadahiko,
AU - Sakamoto,Maki,
AU - Hashimoto,Wataru,
AU - Kashiwada,Keiko,
AU - Sato,Itaru,
AU - Akahori,Fumiaki,
AU - Satoh,Tetsuo,
Y1 - 2006/11/11/
PY - 2006/08/31/received
PY - 2006/11/04/revised
PY - 2006/11/06/accepted
PY - 2006/12/26/pubmed
PY - 2007/3/30/medline
PY - 2006/12/26/entrez
SP - 151
EP - 61
JF - Toxicology and applied pharmacology
JO - Toxicol Appl Pharmacol
VL - 219
IS - 2-3
N2 - Activity of acetylcholinesterase (AChE) and specific binding of [(3)H]quinuclidinyl benzilate (QNB), [(3)H]pirenzepine (PZP) and [(3)H]AF-DX 384 to muscarinic acetylcholine receptor (mAChR) preparations in the striatum, hippocampus and cortex of rats were determined 1, 6 and 11 days after the last treatment with an organophosphate DDVP, a carbamate propoxur or a muscarinic agonist oxotremorine as a reference for 7 and 14 days. AChE activity was markedly decreased in the three regions 1 day after the treatment with DDVP for 7 and 14 days with a gradual recovery 6 to 11 days, and much less decreased 1, 6 and 11 days after the treatment with propoxur for 7 days but not for 14 days in the hippocampus and cortex. The binding of [(3)H]-QNB, PZP and AF-DX 384 in the three regions was generally decreased by the treatment with DDVP for 7 and 14 days. Such down-regulations were generally restored 6 or 11 days after the treatment for 7 but not for 14 days. The down-regulation or up-regulation as measured by [(3)H]-QNB, PZP and AF-DX 384 was observed 1, 6 or 11 days after treatment with propoxur for 7 days and/or 14 days. Repeated treatment with oxotremorine produced similar effects except AChE activity to DDVP. These results suggest that repeated inhibition of AChE activity may usually cause down-regulation of mAChRs with some exception in the hippocampus when a reversible antiChE propoxur is injected.
SN - 0041-008X
UR - https://www.unboundmedicine.com/medline/citation/17188317/Brain_regional_acetylcholinesterase_activity_and_muscarinic_acetylcholine_receptors_in_rats_after_repeated_administration_of_cholinesterase_inhibitors_and_its_withdrawal_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0041-008X(06)00420-0
DB - PRIME
DP - Unbound Medicine
ER -